To address the challenge of identifying and acting on human rights risks deep within a complex global supply chain, AstraZeneca engaged FRDM to develop a data-driven prioritization framework that mapped suppliers as deep as Tier 6, surfaced high-risk entities, and traced those risks back to the direct partners most exposed to compliance challenges.